Literature DB >> 4293728

Increased tumour induction by adenovirus type 12 in thymectomized mice and mice treated with anti-lymphocyte serum.

A C Allison, L D Berman, R H Levey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4293728     DOI: 10.1038/215185a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  14 in total

Review 1.  Biochemical aspects of viral transformation.

Authors:  N P Salzman
Journal:  In Vitro       Date:  1971 Mar-Apr

2.  Prolonged administration of antithymocyte serum in mice. II. Histopathological investigation.

Authors:  E Simpson; S L Nehlsen
Journal:  Clin Exp Immunol       Date:  1971-07       Impact factor: 4.330

Review 3.  Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.

Authors:  T E Starzl; I Penn; C W Putnam; C G Groth; C G Halgrimson
Journal:  Transplant Rev       Date:  1971

4.  Malignant lymphomas in transplantation patients: a review of the world experience.

Authors:  I Penn; T E Starzl
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-01

5.  [Coincidence of plasmacytoma, chronic lymphatic leukemia, and rectal carcinoma occurring together in a family].

Authors:  H P Lohrmann; G Schneider; K Merten; A Tenbaum
Journal:  Blut       Date:  1972-06

Review 6.  Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.

Authors:  E Gleichmann; H Gleichmann
Journal:  Klin Wochenschr       Date:  1973-03-15

Review 7.  Anti-lymphocytic antibody and autoimmune disease: a review.

Authors:  A M Denman
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

8.  Effect of antilymphocyte serum on reovirus infection of mice.

Authors:  S Ida; Y Hinuma
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

9.  Increased Incidence of Lymphoma in C3H/HeJ Adult Mice Injected with Gross Virus and Antithymocytic Serum.

Authors:  D L Vredevoe; E F Hays
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

10.  Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicity.

Authors:  S Soddu; A M Lewis
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.